Women’s Health Strategy

Jessica Toale Excerpts

Thursday 16th April 2026 Commons Chamber

[Karin Smyth]

I thank my hon. Friend for her question. The document contains a long list of actions, with clear dates alongside them, so that she and others—including her constituents—can see what we are saying, and can measure progress.

[Jessica Toale (Bournemouth West) (Lab)]

Ignored, humiliated and misdiagnosed—these are the experiences of far too many women, and far too often, those experiences have tragic consequences. There is no more depressing example of this than the women who were prescribed the banned anti-miscarriage drug diethylstilbestrol, or DES, and the struggle that they, their children and their grandchildren have had in accessing the care and support that they need and deserve. I welcome the steps this Government have taken to improve women’s health outcomes. Will the Minister consider meeting DES campaigners to ensure that their voices and experiences are part of this strategy?

[Karin Smyth]

As we know, and as is documented in the strategy, there is sadly a long list of issues that particularly affect women that have been ignored, and it has taken far too long for women to draw attention to those issues. I understand that my hon. Friend the Minister for patient safety has met DES campaigners, and we will continue to listen to and learn from their experiences as we develop the strategy.